Ling Yang - Concepedia

Author

Ling Yang

University of Oxford ORCID

Also Known As

Anubha Mahajan, Chenxi Qin, Huaidong Du, Jenny Wang, L Y Yang, L Yang, L. Yang, Laiyu Yang, LiCheng Yang, Liming Li

586

Publications

33.5K

Citations

H-Index

185

Concepts

All Affiliations

University of Oxford Peking University Chinese Academy of Medical Sciences & Peking Union Medical College China National Center for Food Safety Risk Assessment Medical Research Council

About

Ling Yang is an author at University of Oxford specializing in medicine, public health, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	38	3.1K
2	Health Sciences	7	7	1.1K
3	Engineering	3	3	74
4	Natural Sciences	2	2	102
5	Arts	1	1	74

Ling Yang

251

Publications

25.1K

Citations

H-Index

Page 1

	Year	Citations
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants Bin Zhou, Rodrigo M. Carrillo‐Larco, Goodarz Danaei, The Lancet	2021	3.4K
Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults Nowell H Phelps, Rosie Singleton, Bin Zhou, The Lancet	2024	1.6K
Design and methods of the Population Assessment of Tobacco and Health (PATH) Study Andrew Hyland, Bridget K. Ambrose, Kevin P. Conway, Tobacco Control	2016	836
Rising rural body-mass index is the main driver of the global obesity epidemic in adults Honor Bixby, James Bentham, Bin Zhou, Nature	2019	718
Tobacco-Product Use by Adults and Youths in the United States in 2013 and 2014 Karin A. Kasza, Bridget K. Ambrose, Kevin P. Conway, New England Journal of Medicine	2017	609
Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004–18 Limin Wang, Bin Zhou, Zhenping Zhao, The Lancet ObesityRepresentative SurveysGlobal HealthRural HealthObesity Management	2021	549
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial Sun Young Rha, Do‐Youn Oh, Patricio Yañez, The Lancet Oncology Chemotherapy Versus PlaceboGastrointestinal OncologyMedicineClinical TrialsImmune Checkpoint Inhibitor	2023	521
Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China Fiona Bragg, Michael V. Holmes, Andri Iona, JAMA	2017	497
Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China Iona Y. Millwood, Robin Walters, Xue W. Mei, The Lancet	2019	487
Estimates of Cancer Incidence in China for 2000 and Projections for 2005 Ling Yang, Donald Maxwell Parkin, Jacques Ferlay, Cancer Epidemiology Biomarkers & Prevention	2005	465

Page 1